Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial
Marshall L Summar, Janet Woodcock · 2026
Read Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial by Marshall L Summar, Janet Woodcock (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13156073.txt.
Description
Marshall Summar and Janet Woodcock argue that rare disease drug trials often fail on math, not on medicine. Their twenty twenty-six perspective article notes that most of the many thousands of rare diseases have no approved therapy. Classic randomized trials demand more patients than a rare disease can supply.
The authors frame the clash as supply and demand: each design demands a sample size, and the patient pool supplies what exists. Designs that use each patient as their own control, or compare against natural history, can cut the needed size five to twenty times with rigor kept. Many failed programs, they say, died of recruitment strain, not weak drugs. They urge regulators to formalize such designs.
Catalog record
| CREATOR | Marshall L Summar, Janet Woodcock |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |